Accessibility Menu
BioRem logo

BioRem

(OTC) BIRMF

Current Price$2.17
Market Cap$35.68M
Since IPO (2012)+1,367%
5 Year+471%
1 Year+36%
1 Month-10%

BioRem Financials at a Glance

Market Cap

$35.68M

Revenue (TTM)

CA$44.45M

Net Income (TTM)

CA$4.98M

EPS (TTM)

$0.19

P/E Ratio

9.86

Dividend

$0.00

Beta (Volatility)

-91.49 (Low)

Price

$2.17

Volume

1,000

Open

$2.17

Previous Close

$2.17

Daily Range

$2.17 - $2.17

52-Week Range

$1.34 - $2.86

Estimated Earnings Date

Aug 25, 2026

BIRMF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About BioRem

Industry

Commercial Services and Supplies

CEO

Derek S. Webb, MBA

Headquarters

Puslinch, ON N0B 2J0, CA

BIRMF Financials

Key Financial Metrics (TTM)

Gross Margin

29.36%

Operating Margin

15.08%

Net Income Margin

11.21%

Return on Equity

37.34%

Return on Capital

37.02%

Return on Assets

15.79%

Earnings Yield

10.14%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$35.68M

Shares Outstanding

16.22M

Volume

1.00K

Avg. Volume

5.41K

Financials (TTM)

Gross Profit

CA$13.05M

Operating Income

CA$6.70M

EBITDA

CA$7.13M

Operating Cash Flow

CA$1.81M

Capital Expenditure

-CA$549.01K

Free Cash Flow

CA$1.26M

Cash & ST Invst.

CA$10.02M

Total Debt

CA$2.66M

BioRem Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

CA$6.83M

+44.5%

Gross Profit

CA$1.40M

+25.8%

Gross Margin

20.42%

N/A

Market Cap

$35.68M

N/A

Market Cap/Employee

$1.05M

N/A

Employees

34

N/A

Net Income

CA$201.86K

+443.2%

EBITDA

CA$276.60K

+21.0%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

CA$10.02M

+4.3%

Total Debt

CA$2.66M

-21.2%

Accounts Receivable

CA$12.21M

+28.8%

Inventory

CA$2.35M

-28.5%

Long Term Debt

CA$1.96M

-27.2%

Short Term Debt

CA$690.18K

+2.8%

Return on Assets

15.79%

N/A

Return on Invested Capital

38.83%

N/A

Free Cash Flow

-CA$1.40M

-130.5%

Operating Cash Flow

-CA$1.13M

-124.1%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MRCRMoro Corporation
$5.33+0.00%
GRNWFGreenlane Renewables Inc.
$0.16+0.00%
TOODThermwood Corporation
$21.00+0.00%
TMGEFThermal Energy International Inc.
$0.11+3.77%

Trending Stocks

Symbol / CompanyPricePrice Chg
AALAmerican Airlines Group
$16.14+0.00%
SOFISoFi Technologies
$17.29+0.01%
NOKNokia
$13.70-0.05%
TQQQProShares Trust - ProShares UltraPro Qqq
$74.44-0.10%

Questions About BIRMF

What is the current price of BioRem?

BioRem is trading at $2.17 per share.

What is the 52-week range for BioRem?

Over the past 52 weeks, BioRem has traded between $1.34 and $2.86.

How much debt does BioRem have?

As of the most recent reporting period, BioRem reported total debt of CA$1.90M.

How much cash does BioRem have on hand?

BioRem reported CA$7.16M in cash and cash equivalents in its most recent financial results.

What is BioRem’s dividend yield?

BioRem does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.